These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression. Tardella M; Di Carlo M; Carotti M; Giovagnoni A; Salaffi F Clin Rheumatol; 2021 Dec; 40(12):4861-4867. PubMed ID: 34313866 [TBL] [Abstract][Full Text] [Related]
8. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients. Fernández-Díaz C; Loricera J; Castañeda S; López-Mejías R; Ojeda-García C; Olivé A; Rodríguez-Muguruza S; Carreira PE; Pérez-Sandoval T; Retuerto M; Cervantes-Pérez EC; Flores-Robles BJ; Hernández-Cruz B; Urruticoechea A; Maíz-Alonso O; Arboleya L; Bonilla G; Hernández-Rodríguez Í; Palma D; Delgado C; Expósito-Molinero R; Ruibal-Escribano A; Álvarez-Rodríguez B; Blanco-Madrigal J; Bernal JA; Vela-Casasempere P; Rodríguez-Gómez M; Fito C; Ortiz-Sanjuán F; Narváez J; Moreno M; López-Corbeto M; Mena-Vázquez N; Aguilera-Cros C; Romero-Yuste S; Ordóñez S; Villa-Blanco I; Gonzélez-Vela MC; Mora-Cuesta V; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R Semin Arthritis Rheum; 2018 Aug; 48(1):22-27. PubMed ID: 29422324 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Mena-Vázquez N; Godoy-Navarrete FJ; Lisbona-Montañez JM; Redondo-Rodriguez R; Manrique-Arija S; Rioja J; Mucientes A; Ruiz-Limón P; Garcia-Studer A; Ortiz-Márquez F; Oliver-Martos B; Cano-García L; Fernández-Nebro A Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047772 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review. Vicente-Rabaneda EF; Atienza-Mateo B; Blanco R; Cavagna L; Ancochea J; Castañeda S; González-Gay MÁ Autoimmun Rev; 2021 Jun; 20(6):102830. PubMed ID: 33887489 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Rituximab in Autoimmune Disease-Associated Interstitial Lung Disease: A Prospective Cohort Study. Mena-Vázquez N; Redondo-Rodríguez R; Rojas-Gimenez M; Romero-Barco CM; Manrique-Arija S; Ortega-Castro R; Hidalgo Conde A; Arnedo Díez de Los Ríos R; Cabrera César E; Espildora F; Aguilar-Hurtado MC; Añón-Oñate I; Pérez-Albaladejo L; Abarca-Costalago M; Ureña-Garnica I; Velloso-Feijoo ML; Irigoyen-Oyarzábal MV; Fernández-Nebro A J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207203 [TBL] [Abstract][Full Text] [Related]
12. Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study. Manfredi A; Cassone G; Furini F; Gremese E; Venerito V; Atzeni F; Arrigoni E; Della Casa G; Cerri S; Govoni M; Petricca L; Iannone F; Salvarani C; Sebastiani M Intern Med J; 2020 Sep; 50(9):1085-1090. PubMed ID: 31661185 [TBL] [Abstract][Full Text] [Related]
13. A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease. Tardella M; Di Carlo M; Carotti M; Ceccarelli L; Giovagnoni A; Salaffi F Inflammopharmacology; 2022 Jun; 30(3):705-712. PubMed ID: 35462572 [TBL] [Abstract][Full Text] [Related]
14. Characteristics and Predictors of Progression Interstitial Lung Disease in Rheumatoid Arthritis Compared with Other Autoimmune Disease: A Retrospective Cohort Study. Mena-Vázquez N; Rojas-Gimenez M; Romero-Barco CM; Manrique-Arija S; Hidalgo Conde A; Arnedo Díez de Los Ríos R; Cabrera César E; Ortega-Castro R; Espildora F; Aguilar-Hurtado MC; Añón-Oñate I; Pérez-Albaladejo L; Abarca-Costalago M; Ureña-Garnica I; Velloso-Feijoo ML; Redondo-Rodriguez R; Fernández-Nebro A Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679492 [TBL] [Abstract][Full Text] [Related]
15. Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre. Md Yusof MY; Kabia A; Darby M; Lettieri G; Beirne P; Vital EM; Dass S; Emery P Rheumatology (Oxford); 2017 Aug; 56(8):1348-1357. PubMed ID: 28444364 [TBL] [Abstract][Full Text] [Related]
16. The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease. Brooks R; Baker JF; Yang Y; Roul P; Kerr GS; Reimold AM; Kunkel G; Wysham KD; Singh N; Lazaro D; Monach PA; Poole JA; Ascherman DP; Mikuls TR; England BR Rheumatology (Oxford); 2022 Nov; 61(12):4667-4677. PubMed ID: 35377443 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options. Chen N; Diao CY; Gao J; Zhao DB Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663 [TBL] [Abstract][Full Text] [Related]
18. Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL Arthritis Rheumatol; 2017 Mar; 69(3):542-549. PubMed ID: 27788297 [TBL] [Abstract][Full Text] [Related]
19. Predictors of progression in rheumatoid arthritis-associated interstitial lung disease: A single-center retrospective study from China. Liu L; Fang C; Sun B; Bao R; Zhang H Int J Rheum Dis; 2022 Jul; 25(7):795-802. PubMed ID: 35633522 [TBL] [Abstract][Full Text] [Related]
20. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis. Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]